Literature DB >> 21912037

Diarrhea-related hemolytic uremic syndrome: unmasking antifactor H antibodies.

Ankur Gupta1, Ambar Khaira, Om P Rathi, Sandeep Mahajan, Dipankar Bhowmik, Sanjay K Agarwal, Suresh C Tiwari.   

Abstract

The cases of hemolytic uremic syndrome (HUS) preceeded by diarrhea are commonly labeled as D+ HUS. However, with severe renal failure or with delayed recovery, such cases should be evaluated for rarer associations like Factor H (FH), I and CD 46 deficiency or mutations. We report such a presentation of a young boy who initially came with diarrhea and had features of HUS with delayed renal recovery. He later turned out to have anti-FH antibody-related HUS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912037

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  2 in total

1.  Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation.

Authors:  F Semsa Cayci; Nilgun Cakar; Veysel Sabri Hancer; Nermin Uncu; Banu Acar; Gokce Gur
Journal:  Pediatr Nephrol       Date:  2012-08-19       Impact factor: 3.714

Review 2.  Anti-complement-factor H-associated glomerulopathies.

Authors:  Marie-Agnes Dragon Durey; Aditi Sinha; Shambhuprasad Kotresh Togarsimalemath; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2016-07-25       Impact factor: 28.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.